Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
TH17炎症诱导的结肠癌发生机制
基本信息
- 批准号:8105255
- 负责人:
- 金额:$ 33.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-06 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAffectAllelesAnaerobic BacteriaBacteriaBacteroides fragilisBone MarrowCD4 Positive T LymphocytesCancer EtiologyCellsCessation of lifeCharacteristicsChimera organismChromosomal InstabilityChronicColitisColonColon CarcinomaColonic NeoplasmsColorectal CancerDataDependenceDevelopmentEpigenetic ProcessEpithelialEpithelial CellsEpitheliumEquilibriumEtiologyFecesGenesGeneticGrowthHematopoieticHumanHyperplasiaIkappaB kinaseImmuneImmune responseImmunologicsInfectionInflammationInflammation MediatorsInflammatoryInflammatory ResponseInfrequent NeoplasmInterleukin-17Interleukin-6Intestinal NeoplasmsIntracolonicKnock-outKnockout MiceLinkLoss of HeterozygosityLymphoidMalignant NeoplasmsMalignant neoplasm of liverMeasurementMediatingMetalloproteasesMicrosatellite InstabilityModelingMusMutationMyelogenousNatural ImmunityNitrogenOral AdministrationOrganOxygenPathogenesisPathway interactionsPremalignantProcessProductionPropertyPublic HealthResearch DesignRoleSignal TransductionSourceSystemT-LymphocyteToll-like receptorsToxinUnited StatesWomanWorkadaptive immunitybasecancer therapycarcinogenesiscellular targetingcolon carcinogenesiscytokineinsightinterleukin-22interleukin-23laser capture microdissectionmalignant stomach neoplasmmenmicrobialnovelnovel strategiespublic health relevancereceptorresponsetumortumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Chronic inflammation and, specifically, infection-associated inflammatory processes, enhance carcinogenesis in the affected organs. Chronic innate immune responses are known to contribute to these processes whereas the contributions of adaptive immunity to carcinogenesis are less clear. We have identified a human colon anaerobic bacterium, enterotoxigenic Bacteroides fragilis (ETBF), that induces a rapid and dramatic increase in colon tumors in multiple intestinal neoplasia mice (MinApc). This model replicates features of human colorectal cancer and our data demonstrate that colon tumorigenesis in this system is dependent, in part, on a novel Stat3/Th17 pathway, thereby defining a distinct role for adaptive immunity in colon cancer pathogenesis. Herein we seek to further define the mechanisms by which Stat3 activation in distinct cellular compartments and the resultant components of the Th17 response crosstalk with the colonic epithelium, inducing genetic and/or epigenetic epithelial cell changes that result in colon tumorigenesis. Our studies will begin to identify links between specific inflammatory mediators and the genetic changes critical to colon carcinogenesis. This work has direct relevance to the design of studies to investigate the pathogenesis of human colorectal cancer and may have implications for novel approaches to colorectal cancer therapy. Colorectal cancer is a major public health problem being the second leading cause of cancer death in the United States in women and men.
PUBLIC HEALTH RELEVANCE: Colon cancer is the second leading cause of cancer death for women and men. The microbial and immunologic mechanisms contributing to colon cancer are unknown. This project will study the immune and genetic mechanisms by which a newly recognized common human stool bacterium called enterotoxigenic Bacteroides fragilis (ETBF) triggers colon tumors in mice, providing new insights into how colon cancer developes and potentially new approaches to colon cancer therapy.
描述(由申请人提供):慢性炎症,特别是与感染相关的炎症过程,增强了受影响器官的致癌作用。已知慢性先天免疫反应会导致这些过程,而适应性免疫对癌变的贡献则不太清楚。我们已经鉴定出人类结肠厌氧菌,肠毒性杀菌剂fragilis(ETBF),该细菌(ETBF)诱导了多个肠道肿瘤小鼠(MinAPC)的结肠肿瘤的快速而急剧增加。该模型复制了人类结肠癌的特征,我们的数据表明,该系统中的结肠肿瘤发生在某种程度上取决于新型的STAT3/TH17途径,从而确定了在结肠癌发病机理中适应性免疫的独特作用。在此,我们寻求进一步定义了在不同的细胞室中激活STAT3的机制,以及Th17反应串扰与结肠上皮的串扰的结果成分,从而诱导遗传和/或表观遗传上皮细胞变化,从而导致结肠肿瘤发生。我们的研究将开始确定特定炎症介质与结肠癌发生至关重要的遗传变化之间的联系。这项工作与研究研究人结直肠癌的发病机理的设计具有直接相关性,并可能对新型结直肠癌治疗的方法有影响。大肠癌是主要的公共卫生问题,是美国男性和男性癌症死亡的第二大原因。
公共卫生相关性:结肠癌是男女癌症死亡的第二大原因。导致结肠癌的微生物和免疫机制尚不清楚。该项目将研究一种新认可的称为肠毒素菌菌素fragilis(ETBF)触发小鼠的结肠肿瘤的免疫和遗传机制,通过该机制,可以提供新的见解,从而提供有关结肠癌如何发展为结肠癌治疗的潜在新方法的新见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DREW M. PARDOLL其他文献
DREW M. PARDOLL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DREW M. PARDOLL', 18)}}的其他基金
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
YAP 在 Treg 功能中的作用和 YAP 靶向癌症免疫治疗
- 批准号:
10547779 - 财政年份:2018
- 资助金额:
$ 33.01万 - 项目类别:
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
YAP 在 Treg 功能中的作用和 YAP 靶向癌症免疫治疗
- 批准号:
10330418 - 财政年份:2018
- 资助金额:
$ 33.01万 - 项目类别:
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
E3连接酶介导的Foxp3表达和免疫抑制机制的控制以及作为免疫治疗靶点的潜力
- 批准号:
10331033 - 财政年份:2018
- 资助金额:
$ 33.01万 - 项目类别:
The Role of EOS in Regulatory T-cell Biology.
EOS 在调节性 T 细胞生物学中的作用。
- 批准号:
8490291 - 财政年份:2010
- 资助金额:
$ 33.01万 - 项目类别:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
TH17炎症诱导的结肠癌发生机制
- 批准号:
8657874 - 财政年份:2010
- 资助金额:
$ 33.01万 - 项目类别:
The Role of EOS in Regulatory T-cell Biology.
EOS 在调节性 T 细胞生物学中的作用。
- 批准号:
8683077 - 财政年份:2010
- 资助金额:
$ 33.01万 - 项目类别:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
产肠毒素脆弱拟杆菌:结肠癌发生的细菌启动子
- 批准号:
8707985 - 财政年份:2010
- 资助金额:
$ 33.01万 - 项目类别:
PD-1/PD-L1 modulation in cancer therapy
癌症治疗中的 PD-1/PD-L1 调节
- 批准号:
10355495 - 财政年份:2010
- 资助金额:
$ 33.01万 - 项目类别:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
产肠毒素脆弱拟杆菌:结肠癌发生的细菌启动子
- 批准号:
8137121 - 财政年份:2010
- 资助金额:
$ 33.01万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 33.01万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 33.01万 - 项目类别:
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 33.01万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 33.01万 - 项目类别:
Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
- 批准号:
10742569 - 财政年份:2023
- 资助金额:
$ 33.01万 - 项目类别: